JP2020530776A5 - - Google Patents
Info
- Publication number
- JP2020530776A5 JP2020530776A5 JP2020520424A JP2020520424A JP2020530776A5 JP 2020530776 A5 JP2020530776 A5 JP 2020530776A5 JP 2020520424 A JP2020520424 A JP 2020520424A JP 2020520424 A JP2020520424 A JP 2020520424A JP 2020530776 A5 JP2020530776 A5 JP 2020530776A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- percentage homology
- variable region
- Prior art date
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023190606A JP7610680B2 (ja) | 2017-06-25 | 2023-11-08 | 抗ｐｄ－ｌ１抗体とその作製及び使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762524553P | 2017-06-25 | 2017-06-25 | |
| US62/524,553 | 2017-06-25 | ||
| PCT/US2018/039144 WO2019005634A2 (en) | 2017-06-25 | 2018-06-22 | ANTI-PD-L1 ANTIBODIES AND METHODS OF PREPARATION AND USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023190606A Division JP7610680B2 (ja) | 2017-06-25 | 2023-11-08 | 抗ｐｄ－ｌ１抗体とその作製及び使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020530776A JP2020530776A (ja) | 2020-10-29 |
| JP2020530776A5 true JP2020530776A5 (https=) | 2022-01-17 |
| JPWO2019005634A5 JPWO2019005634A5 (https=) | 2022-01-17 |
| JP7383605B2 JP7383605B2 (ja) | 2023-11-20 |
Family
ID=64742649
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520424A Active JP7383605B2 (ja) | 2017-06-25 | 2018-06-22 | 抗ｐｄ－ｌ１抗体とその作製及び使用方法 |
| JP2023190606A Active JP7610680B2 (ja) | 2017-06-25 | 2023-11-08 | 抗ｐｄ－ｌ１抗体とその作製及び使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023190606A Active JP7610680B2 (ja) | 2017-06-25 | 2023-11-08 | 抗ｐｄ－ｌ１抗体とその作製及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11560431B2 (https=) |
| EP (1) | EP3645738A4 (https=) |
| JP (2) | JP7383605B2 (https=) |
| CN (2) | CN116535508A (https=) |
| WO (1) | WO2019005634A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020098785A1 (zh) * | 2018-11-16 | 2020-05-22 | 南京金斯瑞生物科技有限公司 | 人源化抗人pd-l1单克隆抗体及其制备方法和用途 |
| CN109929037B (zh) * | 2019-04-01 | 2023-03-17 | 华博生物医药技术（上海）有限公司 | 针对程序性死亡配体的结合物及其应用 |
| EP4118120A4 (en) | 2020-03-12 | 2024-04-17 | Immune-ONC Therapeutics, Inc. | NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS |
| BR112023016025A2 (pt) * | 2021-02-10 | 2023-10-31 | Jiangxi Jemincare Group Co Ltd | Anticorpo anti-pd-l1 e uso dos mesmos |
| WO2024160721A1 (en) | 2023-01-30 | 2024-08-08 | Kymab Limited | Antibodies |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2494107C2 (ru) * | 2005-05-09 | 2013-09-27 | Оно Фармасьютикал Ко., Лтд. | Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами |
| AU2009333580B2 (en) * | 2008-12-09 | 2016-07-07 | Genentech, Inc. | Anti-PD-L1 antibodies and their use to enhance T-cell function |
| HRP20201595T1 (hr) * | 2011-11-28 | 2020-12-11 | Merck Patent Gmbh | Anti-pd-l1 protutijela i njihova uporaba |
| CN113967253A (zh) | 2012-05-15 | 2022-01-25 | 百时美施贵宝公司 | 通过破坏pd-1/pd-l1信号传输的免疫治疗 |
| CA2916681A1 (en) * | 2013-07-16 | 2015-01-22 | Genentech, Inc. | Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors |
| MX2016007885A (es) * | 2013-12-17 | 2017-01-11 | Genentech Inc | Metodos de tratamiento de cancer usando antagonistas de union del eje de pd-1 y un anticuerpo anti-cd20. |
| TWI680138B (zh) * | 2014-01-23 | 2019-12-21 | 美商再生元醫藥公司 | 抗ｐｄ-ｌ１之人類抗體 |
| DK3221355T3 (da) * | 2014-11-20 | 2020-12-07 | Hoffmann La Roche | Kombinationsbehandling med T-celleaktiverende bispecifikke antigenbindende molekyler CD3 og folatreceptor 1 (FolR1) samt PD-1-aksebindende antagonister |
| EP3763827A1 (en) * | 2015-05-29 | 2021-01-13 | F. Hoffmann-La Roche AG | Pd-l1 promoter methylation in cancer |
| CN116948035A (zh) * | 2017-06-25 | 2023-10-27 | 西雅图免疫公司 | 多特异性抗体及其制备和使用方法 |
| KR102785809B1 (ko) * | 2017-11-02 | 2025-03-26 | 시스트이뮨, 인코포레이티드 | 이중특이성 항체 및 이의 제조 및 사용 방법 |
| US20210008113A1 (en) * | 2018-03-27 | 2021-01-14 | Systimmune, Inc. | Methods of making and using guidance and navigation control proteins |
-
2018
- 2018-06-22 EP EP18823242.5A patent/EP3645738A4/en active Pending
- 2018-06-22 JP JP2020520424A patent/JP7383605B2/ja active Active
- 2018-06-22 CN CN202310737246.6A patent/CN116535508A/zh active Pending
- 2018-06-22 US US16/615,112 patent/US11560431B2/en active Active
- 2018-06-22 WO PCT/US2018/039144 patent/WO2019005634A2/en not_active Ceased
- 2018-06-22 CN CN201880038275.0A patent/CN110831972B/zh active Active
-
2023
- 2023-11-08 JP JP2023190606A patent/JP7610680B2/ja active Active